Ronald D. Lewis

Ronald D. (Ron) Lewis, II, Ph.D. is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as the Head of CMC at Aardvark Therapeutics. With a robust background as a Principal Consultant at R D Lewis & Associates and experience as an Adjunct Faculty member at Columbia College, Ronald has held prominent positions at MEI Pharma, including Sr. Director of Technical & CMC Operations, as well as various director-level roles in CMC Operations. Prior to this, Ronald was the Director of Medicinal Chemistry at Intercept Pharmaceuticals. Ronald holds a Ph.D. in Chemistry from Wesleyan University and completed a post-doctoral fellowship in Monoclonal Antibodies at Scripps Research.